Diagnostic Value of Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging for Focal Liver Lesions: A Meta-Analysis

Ultrasound in Medicine and Biology

Volumn 37, Issue 6, 2011, Pages 854-861

  Xie, Limei ^a   Guang, Yang ^a   Ding, Hailong ^a   Cai, Ailu ^a   Huang, Ying ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Contrast enhanced computed tomography (CECT); Contrast enhanced magnetic resonance imaging (CEMRI); Contrast enhanced ultrasound (CEUS); Focal liver lesions (FLLs); Meta analysis

Indexed keywords

COMPUTED TOMOGRAPHY; CONTRAST ENHANCED ULTRASOUND; CONTRAST-ENHANCED; FOCAL LIVER LESIONS; META-ANALYSIS;

COMPUTERIZED TOMOGRAPHY; FOCUSING; RESONANCE; TOMOGRAPHY; ULTRASONICS;

MAGNETIC RESONANCE IMAGING;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCED ECHOGRAPHY; CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTERMETHOD COMPARISON; LIVER INJURY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYSTEMATIC REVIEW;

CONTRAST MEDIA; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 79956117445     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2011.03.006     Document Type: Article

References (60)

1. Bacigalupo L., Aufort S., Eberlé M.C., Assenat E., Ychou M., Gallix B. Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT. Radiol Med 2010, 115:1087-1100.
2. Bartolotta T.V., Taibbi A., Midiri M., La Grutta L., De Maria M., Lagalla R. Characterisation of focal liver lesions undetermined at grey-scale US: Contrast-enhanced US versus 64-row MDCT and MRI with liver-specific contrast agent. Radiol Med 2010, 115:714-731.
3. Basilico R., Blomley M.J., Harvey C.J., Filippone A., Heckemann R.A., Eckersley R.J., Cosgrove D.O. Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?. Eur J Radiol 2002, 41:184-191.
4. Bokor D., Chambers J.B., Rees P.J., Mant T.G., Luzzani F., Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 2001, 36:104-109.
5. Brancatelli G., Federle M.P., Grazioli L., Blachar A., Peterson M.S., Thaete L. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001, 219:61-68.
6. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., Rode's J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001, 35:421-430.
7. Burns P.N., Wilson S.R., Simpson D.H. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000, 35:58-71.
8. Catala V., Nicolau C., Vilana R., Pages M., Bianchi L., Sanchez M., Bru C. Characterization of focal liver lesions: Comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 2007, 17:1066-1073.
9. Chami L., Lassau N., Malka D., Ducreux M., Bidault S., Roche A., Elias D. Benefits of contrast-enhanced sonography for the detection of liver lesions: Comparison with histologic findings. Am J Roentgenol 2008, 190:683-690.
10. Claudon M., Cosgrove D., Albrecht T., Bolondi L., Bosio M., Calliada F., Correas J.M., Darge K., Dietrich C., D'Onofrio M., Evans D.H., Filice C., Greiner L., Jäger K., Jong N., Leen E., Lencioni R., Lindsell D., Martegani A., Meairs S., Nolsøe C., Piscaglia F., Ricci P., Seidel G., Skjoldbye B., Solbiati L., Thorelius L., Tranquart F., Weskott H.P., Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-Update 2008. Ultraschall Med 2008, 29:28-44.
11. Cho C.S., Curran S., Schwartz L.H., Kooby D.A., Klimstra D.S., Shia J., Munoz A., Fong Y., Jarnagin W.R., DeMatteo R.P., Blumgart L.H., D'Angelica M.I. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 2008, 206:480-488.
12. Cieszanowski A., Szeszkowski W., Golebiowski M., Bielecki D.K., Grodzicki M., Pruszynski B. Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence. Eur Radiol 2002, 12:2273-2279.
13. Collier J., Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998, 27:273-278.
14. Dai Y., Chen M.H., Fan Z.H., Yan K., Yin S.S., Zhang X.P. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res 2008, 38:281-290.
15. de Groot M.C., van Zwieten-Boot B.J., van Grootheest A.C. Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent. Ned Tijdschr Geneeskd 2004, 148:1887-1888.
16. Devillé W.L., Bezemer P.D., Bouter L.M. Publications on diagnostic test evaluation in family medicine journals: An optimal search strategy. J Clin Epidemiol 2000, 53:65-69.
17. Dill-Macky M.J., Burns P.N., Kahlili K., Wilson S.R. Focal hepatic masses: Enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002, 222:95-102.
18. D'Onofrio M., Faccioli N., Zamboni G., Malagò R., Caffarri S., Fattovich G., Mucelli R.P. Focal liver lesions in cirrhosis: Value of contrast-enhanced ultrasonography compared with Doppler ultrasound and α-fetoprotein levels. Radiol med 2008, 113:978-991.
19. D'souza M.M., Sharma R., Mondal A., Jaimini A., Tripathi M., Saw S.K., Singh D., Mishra A., Tripathi R.P. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. Nucl Med Commun 2009, 30:117-125.
20. Gallotti A., D'Onofrio M., Ruzzenente A., Martone E., De Robertis R., Guglielmi A., Pozzi Mucelli R. Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma. Radiol Med 2009, 114:1094-1105.
21. Goodacre S., Sutton A.J., Sampson F.C. Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005, 143:129-139.
22. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
23. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
24. Isozaki T., Numata K., Kiba T., Hara K., Morimoto M., Sakasuchi T., Sekihara H., Kubota T., Shimada H., Morizane T., Tanaka K. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003, 229:798-805.
25. Kim C.K., Lim J.H., Lee W.J. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic liver. J Ultrasound Med 2001, 20:99-104.
26. Kong G., Jackson C., Koh D.M., Lewington V., Sharma B., Brown G., Cunningham D., Cook G.J. The use of 18F-FDG PET/CT in colorectal liver metastases-comparison with CT and liver MRI. Eur J Nucl Med Mol Imaging 2008, 35:1323-1329.
27. Konopke R., Kersting S., Bergert H., Bloomenthal A., Gastmeier J., Saeger H.D., Bunk A. Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007, 22:201-207.
28. Krix M., Kiessling F., Essig M., Herth F., Karcher A., Le-Huu M., Kauczor H.U., Delorme S. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol 2004, 39:216-222.
29. Leen E., Angerson W.J., Yarmenitis S., Bongartz G., Blomley M., Del Maschio A., Summaria V., Maresca G., Pezzoli C., Llull J.B. Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002, 41:200-206.
30. Leen E., Ceccotti P., Kalogeropoulou C., Angerson W.J., Moug S.J., Horgan P.G. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. Am J Roentgenol 2006, 86:1551-1559.
31. Lim A.K., Patel N., Eckersley R.J., Taylor-Robinson S.D., Cosgrove D.O., Blomley M.J. Evidence for spleen-specific uptake of a microbubble contrast agent: A quantitative study in healthy volunteers. Radiology 2004, 231:785-788.
32. Lu M.D., Yu X.L., Li A.H., Jiang T.A., Chen M.H., Zhao B.Z., Zhou X.D., Wang J.R. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: A multi-center study in China. Ultrasound Med Biol 2007, 33:1736-1749.
33. Luo B.M., Wen Y.L., Yang H.Y., Zhi H., Ou B., Ma J.H., Pan J.S., Dai X.N. Differentiation between malignant and benign nodules in the liver: Use of contrast C3-MODE technology. World J Gastroenterol 2005, 11:2402-2407.
34. Luo W., Numata K., Morimoto M., Nozaki A., Ueda M., Kondo M., Morita S., Tanaka K. Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies. World J Gastroenterol 2010, 16:2109-2119.
35. Mann R.M., Hoogeveen Y.L., Blickman J.G., Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: A review of existing literature. Breast Cancer Res Treat 2008, 107:1-14.
36. Mitchell A.M., Brown M.D., Menown I.B., Kline J.A. Novel protein markers of acute coronary syndrome complications in low-risk outpatients: A systematic review of potential use in the emergency department. Clin Chem 2005, 51:2005-2012.
37. Moses L.E., Shapiro D., Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: Data analytic approaches and some additional considerations. Stat Med 1993, 12:1293-1316.
38. Numata K., Isozaki T., Morimoto M., Sugimori K., Katsuaki R., Morizane T., Katsuaki T. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography. World J Gastroenterol 2006, 12:6290-6298.
39. Pan L., Han Y., Sun X., Liu J., Gang H. FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: A meta-analysis. J Cancer Res Clin Oncol 2010, 7:1007-1022.
40. Parikh T., Drew S.J., Lee V.S., Wong S., Hecht E.M., Babb J.S., Taouli B. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging. Radiology 2008, 246:812-822.
41. Pirovano G., Vanzulli A., Marti-Bonmati L., Grazioli L., Manfredi R., Greco A., Holzknecht N., Daldrup-Link H.E., Rummeny E., Hamm B., Arneson V., Imperatori L., Kirchin M.A., Spinazzi A. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. Am J Roentgenol 2000, 75:1111-1120.
42. Quaia E., Alaimo V., Baratella E., Medeot A., Midiri M., Cova M.A. The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity implications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiol 2009, 19:651-663.
43. Quaia E., D'Onofrio M., Palumbo A., Rossi S., Bruni S., Cova M. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: Diagnostic performance and confidence. Eur Radiol 2006, 16:1599-1609.
44. Regge D., Campanella D., Anselmetti G.C., Cirillo S., Gallo T.M., Muratore A., Capussotti L., Galatola G., Floriani I., Aglietta M. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 2006, 61:338-347.
45. Reimer P., Schneider G., Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: Properties, clinical development and applications. Eur Radiol 2004, 14:559-578.
46. Romanini L., Passamonti M., Aiani L., Cabassa P., Raieli G., Montermini I., Martegani A., Grazioli L., Calliada F. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: A multicentre Italian experience. Eur Radiol 2007, 17:F99-F106.
47. Sackett D.L., Haynes R.B. The architecture of diagnostic research. BMJ 2002, 324:539-541.
48. Schneider M., Arditi M., Barrau M.B., Brochot J., Broillet A., Ventrone R., Yan F. BR1: A new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol 1995, 30:451-457.
49. Seltzer S.E., Getty D.J., Pickett R.M., Swets J.A., Sica G., Brown J., Saini S., Mattrey R.F., Harmon B., Francis I.R., Chezmar J., Schnall M.O., Siegelman E.S., Ballerini R., Bhat S. Multimodality diagnosis of liver tumors: Feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model. Acad Radiol 2002, 9:256-269.
50. Sodhi K.S., Sidhu R., Gulati M., Saxena A., Suri S., Chawla Y. Role of tissue harmonic imaging in focal hepatic lesions: Comparison with conventional sonography. J Gastroenterol Hepatol 2005, 20:1488-1493.
51. Staub F., Tournoux-Facon C., Roumy J., Chaigneau C., Morichaut-Beauchant M., Levillain P., Prevost C., Aubé C., Lebigot J., Oberti F., Galtier J.B., Laumonier H., Trillaud H., Bernard P.H., Blanc J.F., Sironneau S., Machet F., Drouillard J., de Ledinghen V., Couzigou P., Foucher P., Castéra L., Tranquard F., Bacq Y., d'Altéroche L., Ingrand P., Tasu J.P. Liver fibrosis staging with contrast-enhanced ultrasonography: Prospective multicenter study compared with METAVIR scoring. Eur Radiol 2009, 19:1991-1997.
52. Suzuki S., Iijima H., Moriyasu F., Sasaki S., Yanagisawa K., Miyahara T., Oguma K., Yoshida M., Horibe T., Ito N., Kakizaki D., Abeb K., Tsuchiya K. Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of Levovist contrast ultrasound: Comparative study with SPIO-MRI. Hepatol Res 2004, 29:122-126.
53. Tateishi U., Hasegawa T., Muramatsu Y., Moriyama N. Hepatic metastases of soft tissue angiosarcoma: CT and MR imaging findings. Abdom Imaging 2003, 28:660-664.
54. Torzilli G. Adverse effects associated with SonoVue use. Expert Opin Drug Saf 2005, 4:399-401.
55. van Houwelingen H.C., Arends L.R., Stijnen T. Advanced methods in meta-analysis: Multivariate approach and meta-regression. Stat Med 2002, 21:589-624.
56. von Herbay A., Vogt C., Häussinger D. Late-phase pulse-inversion sonography using the contrast agent Levovist: Differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 2002, 179:1273-1279.
57. Wang Z.L., Tang J., Weskott H.P., Li J.L., Wang W., Luo Y.K., An L.C., Xu J.H. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: Characterization with contrast-enhanced ultrasound. J Gastroenterol Hepatol 2008, 23:1511-1519.
58. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
59. Wu W., Chen M.H., Yin S.S., Yan K., Fan Z.H., Yang W., Dai Y., Huo L., Li J.Y. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. Am J Roentgenol 2006, 87:752-761.
60. Zamora J., Abraira V., Muriel A., Khan K., Coomarasamy A. Meta-DiSc: A software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.